About
Manaolana Oncology is a biotechnology company developing novel oncology therapeutics by identifying new cancer targets and creating differentiated antibody products, including antibody-drug conjugates, through a joint venture with MD Anderson Cancer Center.
Explore Manaolana Oncology's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.